BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21658007)

  • 1. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
    Flesch BK; Petershofen EK; Bux J
    Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated (immune) transfusion-related acute lung injury.
    Bux J
    Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-related acute lung injury: Current understanding and preventive strategies.
    Vlaar AP
    Transfus Clin Biol; 2012 Jun; 19(3):117-24. PubMed ID: 22682310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
    Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
    Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related acute lung injury, an evolving syndrome: the road of discovery, with emphasis on the role of the Mayo Clinic.
    Stubbs JR
    Transfus Med Rev; 2011 Jan; 25(1):66-75. PubMed ID: 21134628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in laboratory assays for nonhemolytic transfusion reactions.
    Hirayama F
    Transfusion; 2010 Jan; 50(1):252-63. PubMed ID: 19778335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
    Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
    Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion-related acute lung injury].
    Vlaar AP; Juffermans NP
    Ned Tijdschr Geneeskd; 2013; 157(11):A5524. PubMed ID: 23484511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRALI risk reduction: donor and component management strategies.
    Eder AF; Benjamin RJ
    J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights into the mechanism of transfusion-related acute lung injury.
    Sachs UJ
    Curr Opin Hematol; 2011 Nov; 18(6):436-42. PubMed ID: 21912251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.